EGFR shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemEGFR shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29301-SH
Quantity20 µg
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Nameepidermal growth factor receptor
NCBI Gene AliasesERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Involvement of Lipid Rafts in the Invasion of Opportunistic Bacteria Serratia into Eukaryotic CellsInternational journal of molecular sciencesMay 20, 2023Berson Y, Khaitlina S, Tsaplina O.

(2) CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral canceriScienceMarch 17, 2023Lin YC, Hua CH, Lu HM, Huang SW, Chen Y, Tsai MH, Lin FY, Canoll P, Chiu SC, Huang WH, et al.IMSR_JAX:005557" ,, Oligonucleotides,Oligonucleotides,Oligonucleotides ,, EGFR shRNA Plasmid (h),Santa Cruz Biotechnology,"Cat# sc-29301-SH,RRID: N/A" HLA-G shRNA Plasmid (h),Santa Cruz Biotechnology,"Cat# sc-42920-SH,RRID: N/A" Cryopyrin/NALP3/NLRP3

(3) EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulationNature cell biologyAugust 1, 2022Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, Hatanpaa KJ, Garzon-Muvdi T, Koduru P, Nayab A, et al.

(4) Grb2 interacts with necrosome components and is involved in rasfonin-induced necroptosisCell death discoveryJuly 13, 2022Hou B, Huang H, Li Y, Liang J, Xi Z, Jiang X, Liu L, Li E.

(5) AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer CellsCancersJune 21, 2022Jeong S, Farag AK, Yun HK, Jeong YA, Kim DY, Jo MJ, Park SH, Kim BR, Kim JL, Kim BG, et al.

(6) Euphorbiasteroid Abrogates EGFR and Wnt/β-Catenin Signaling in Non-Small-Cell Lung Cancer Cells to Impart Anticancer ActivityMolecules (Basel, Switzerland)June 14, 2022Kim NY, Mohan CD, Chinnathambi A, Alharbi SA, Sethi G, Rangappa KS, Ahn KS.

(7) Molecular mechanism of the uptake and toxicity of EGF-LipoAgNPs in EGFR-overexpressing cancer cellsBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieJune 1, 2022Skóra B, Szychowski KA.

(8) Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progressionThe Journal of biological chemistryJune 1, 2022Beauvais DM, Nelson SE, Adams KM, Stueven NA, Jung O, Rapraeger AC.

(9) Piperine Attenuates Lithocholic Acid-Stimulated Interleukin-8 by Suppressing Src/EGFR and Reactive Oxygen Species in Human Colorectal Cancer CellsAntioxidants (Basel, Switzerland)March 10, 2022Li S, Nguyen TT, Ung TT, Sah DK, Park SY, Lakshmanan VK, Jung YD.

(10) Dual clathrin and integrin signaling systems regulate growth factor receptor activationNature communicationsFebruary 16, 2022Alfonzo-Méndez MA, Sochacki KA, Strub MP, Taraska JW.

(11) The Globular C1q Receptor Is Required for Epidermal Growth Factor Receptor Signaling during Candida albicans InfectionmBioDecember 21, 2021Phan QT, Lin J, Solis NV, Eng M, Swidergall M, Wang F, Li S, Gaffen SL, Chou TF, Filler SG.

(12) Bacterial Outer Membrane Protein OmpX Regulates β1 Integrin and Epidermal Growth Factor Receptor (EGFR) Involved in Invasion of M-HeLa Cells by Serratia proteamaculansInternational journal of molecular sciencesDecember 9, 2021Tsaplina O, Bozhokina E.

(13) Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2Molecular therapy. Nucleic acidsSeptember 3, 2021Seok HJ, Choi YE, Choi JY, Yi JM, Kim EJ, Choi MY, Lee SJ, Bae IH.

(14) Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axisMedical oncology (Northwood, London, England)August 6, 2021Sinto MS, Thomas S, Kannan S.

(15) Loss of CPAP causes sustained EGFR signaling and epithelial-mesenchymal transition in oral cancerOncotargetApril 13, 2021Gudi RR, Janakiraman H, Howe PH, Palanisamy V, Vasu C.

(16) Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated SignalingJournal of virologyFebruary 24, 2021Wang Q, Pan W, Wang S, Pan C, Ning H, Huang S, Chiu SH, Chen JL.

(17) Mechanism underlying resveratrol's attenuation of paclitaxel cytotoxicity in human breast cancer cells: Role of the SIRT1-FOXO1-HER3 signaling pathwayCancer treatment and research communicationsJanuary 1, 2021Fukui M, Choi HJ, Wang P, Zhu BT.

(18) Activation of EphA2-EGFR signaling in oral epithelial cells by Candida albicans virulence factorsPLoS pathogensJanuary 1, 2021Swidergall M, Solis NV, Millet N, Huang MY, Lin J, Phan QT, Lazarus MD, Wang Z, Yeaman MR, Mitchell AP, et al.

(19) Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancerCell biochemistry and functionDecember 1, 2020Xie Y, Gu J, Qin Z, Ren Z, Wang Y, Shi H, Chen B.

(20) Regulatory role of transcription factor HBP1 in anticancer efficacy of EGFR inhibitor erlotinib in HNSCCHead & neckOctober 1, 2020Chan CY, Chang CM, Chen YH, Sheu JJ, Lin TY, Huang CY.

Be the First to Write a Review!